The effect of BMI on the outcomes of CDK 4/6 inhibitor therapy in HR-positive metastatic breast cancer patients.

Basit Öğe Kaydı
dc.contributor.authorCaglayan, Dilek
dc.contributor.authorKocak, Mehmet Zahid
dc.contributor.authorGeredeli, Caglayan
dc.contributor.authorTatli, Ali Murat
dc.contributor.authorEryolmaz, Melek Karakurt
dc.contributor.authorGoksu, Sema Sezgin
dc.contributor.authorAraz, Murat
dc.date.accessioned2024-02-23T14:45:22Z
dc.date.available2024-02-23T14:45:22Z
dc.date.issued2022
dc.departmentNEÜen_US
dc.descriptionAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 03-07, 2022 -- ELECTR NETWORKen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue16en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12452/17396
dc.identifier.volume40en_US
dc.identifier.wosWOS:000863680302544en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofJournal Of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleThe effect of BMI on the outcomes of CDK 4/6 inhibitor therapy in HR-positive metastatic breast cancer patients.en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu